...
首页> 外文期刊>AIDS Research and Human Retroviruses >Detection of low-frequency HIV type 1 reverse transcriptase drug resistance mutations by ultradeep sequencing in naive HIV type 1-infected individuals
【24h】

Detection of low-frequency HIV type 1 reverse transcriptase drug resistance mutations by ultradeep sequencing in naive HIV type 1-infected individuals

机译:通过超深度测序检测初次感染HIV 1型个体的低频HIV 1型逆转录酶耐药性突变

获取原文
获取原文并翻译 | 示例
           

摘要

Genotypic resistance testing is recommended to evaluate the susceptibility of HIV to antiretroviral drugs. These tests are based on bulk population sequencing and thus consider only variants representing more than 20% of the viral population, whereas next generation sequencing methods allow detection below this threshold. We aimed to evaluate the potential use of ultradeep pyrosequencing (UDPS) for genotypic resistance testing in clinical routine at the University Hospital of Bordeaux, France. We performed UDPS on reverse transcriptase (RT) from 47 HIV-1 individuals, naive of antiretroviral treatment and for whom genotypic resistance testing was requested for clinical management in 2011-2012. In 8.5% of the patients, only low-frequency variants harboring RT drug resistance mutations were detected raising the question of their clinical significance. Rilpivirine-associated resistance mutations were detected in 19.1% of our population study. To conclude, UDPS could become a routine tool for the evaluation of HIV-infected patients in hospital laboratories.
机译:建议进行基因型耐药性测试,以评估HIV对抗逆转录病毒药物的敏感性。这些测试基于总体种群测序,因此仅考虑代表超过20%病毒种群的变异体,而下一代测序方法则允许在此阈值以下进行检测。我们旨在评估法国波尔多大学医院临床常规中超深焦磷酸测序(UDPS)在基因型耐药性检测中的潜在用途。我们对47位HIV-1个体的逆转录酶(RT)进行了UDPS,他们没有进行过抗逆转录病毒治疗,并且在2011-2012年要求对其进行基因型耐药性测试以进行临床管理。在8.5%的患者中,仅检测到具有RT耐药性突变的低频变异,这提出了其临床意义的问题。在我们的人口研究中,有19.1%的患者检出了与Rilpivirine相关的耐药性突变。总之,UDPS可以成为评估医院实验室中HIV感染患者的常规工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号